Molecular diagnostic firm wants to catch multiple sclerosis sooner and with greater accuracy
Multiple sclerosis is a debilitating and unpredictable disease that often is difficult to diagnose. Gaithersburg, Maryland-based molecular diagnostic startup DioGenix wants to change all that. The company is conducting a multicenter validation trial to show that its MSPrecise diagnostic technology can look for specific DNA changes in cerebrospinal fluid that ultimately causes auto-immune diseases like […]